|
CA1156952A
(en)
|
1979-06-08 |
1983-11-15 |
Research Council Of Alberta |
Formation of coke from heavy crude oils in the presence of calcium carbonate
|
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5262177A
(en)
|
1986-02-07 |
1993-11-16 |
Oncogen |
Recombinant viruses encoding the human melanoma-associated antigen
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5171665A
(en)
|
1989-04-17 |
1992-12-15 |
Oncogen |
Monoclonal antibody to novel antigen associated with human tumors
|
|
DK0474727T3
(da)
|
1989-05-19 |
1998-01-12 |
Genentech Inc |
HER2 ekstracellulært domæne
|
|
US5204253A
(en)
|
1990-05-29 |
1993-04-20 |
E. I. Du Pont De Nemours And Company |
Method and apparatus for introducing biological substances into living cells
|
|
US5830702A
(en)
|
1990-10-31 |
1998-11-03 |
The Trustees Of The University Of Pennsylvania |
Live, recombinant listeria monocytogenes and production of cytotoxic T-cell response
|
|
US5342774A
(en)
|
1991-05-23 |
1994-08-30 |
Ludwig Institute For Cancer Research |
Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
|
|
FR2686896B1
(fr)
|
1992-01-31 |
1995-01-06 |
Pasteur Institut |
Mutant attenue de listeria monocytogenes; souche recombinante de listeria monocytogenes, utilisation comme vecteurs heterologues d'antigenes vaccinal et utilisation comme vaccin ou composition diagnostique.
|
|
US5633234A
(en)
|
1993-01-22 |
1997-05-27 |
The Johns Hopkins University |
Lysosomal targeting of immunogens
|
|
US5679647A
(en)
|
1993-08-26 |
1997-10-21 |
The Regents Of The University Of California |
Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
|
|
US5804566A
(en)
|
1993-08-26 |
1998-09-08 |
The Regents Of The University Of California |
Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
|
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US7820180B2
(en)
|
2004-09-24 |
2010-10-26 |
The Trustees Of The University Of Pennsylvania |
Listeria-based and LLO-based vaccines
|
|
US7794729B2
(en)
|
1994-11-08 |
2010-09-14 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for immunotherapy of cancer
|
|
US7662396B2
(en)
*
|
2001-03-26 |
2010-02-16 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
US20070264279A1
(en)
*
|
1994-11-08 |
2007-11-15 |
Claudia Gravekamp |
Compositions and methods comprising a MAGE-b antigen
|
|
US6051237A
(en)
|
1994-11-08 |
2000-04-18 |
The Trustees Of The University Of Pennsylvania |
Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
|
|
US8114414B2
(en)
*
|
1994-11-08 |
2012-02-14 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treatment of cervical cancer
|
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
|
US5681570A
(en)
|
1995-01-12 |
1997-10-28 |
Connaught Laboratories Limited |
Immunogenic conjugate molecules
|
|
US6017705A
(en)
|
1995-03-14 |
2000-01-25 |
Ludwig Institute For Cancer Research |
Isolated nucleic acid molecules which are members of the MAGE-B family and uses thereof
|
|
US5877159A
(en)
|
1995-05-03 |
1999-03-02 |
University Of Maryland At Baltimore |
Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same
|
|
US5922687A
(en)
|
1995-05-04 |
1999-07-13 |
Board Of Trustees Of The Leland Stanford Junior University |
Intracellular delivery of nucleic acids using pressure
|
|
JPH10510433A
(ja)
|
1995-06-06 |
1998-10-13 |
アイシス・ファーマシューティカルス・インコーポレーテッド |
高いキラル純度のホスホロチオエート結合を有するオリゴヌクレオチド
|
|
US5643599A
(en)
|
1995-06-07 |
1997-07-01 |
President And Fellows Of Harvard College |
Intracellular delivery of macromolecules
|
|
WO1996040947A1
(en)
|
1995-06-07 |
1996-12-19 |
Washington University |
Recombinant bacterial system with environmentally limited viability
|
|
US5985662A
(en)
|
1995-07-13 |
1999-11-16 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of hepatitis B virus replication
|
|
US5824538A
(en)
|
1995-09-06 |
1998-10-20 |
The United States Of America As Represented By The Secretary Of The Army |
Shigella vector for delivering DNA to a mammalian cell
|
|
US5922583A
(en)
*
|
1995-10-17 |
1999-07-13 |
Biostar Inc. |
Methods for production of recombinant plasmids
|
|
DE19541450C2
(de)
|
1995-11-07 |
1997-10-02 |
Gsf Forschungszentrum Umwelt |
Genkonstrukt und dessen Verwendung
|
|
US6479258B1
(en)
|
1995-12-07 |
2002-11-12 |
Diversa Corporation |
Non-stochastic generation of genetic vaccines
|
|
US6740506B2
(en)
|
1995-12-07 |
2004-05-25 |
Diversa Corporation |
End selection in directed evolution
|
|
WO1998004720A1
(en)
|
1996-07-26 |
1998-02-05 |
Sloan-Kettering Institute For Cancer Research |
Method and reagents for genetic immunization
|
|
US5858682A
(en)
|
1996-08-02 |
1999-01-12 |
Pharmingen |
E2A/pbx1 fusion protein specific monoclonal antibodies
|
|
CA2266656A1
(en)
|
1996-09-17 |
1998-03-26 |
Chiron Corporation |
Compositions and methods for treating intracellular diseases
|
|
WO1998046811A1
(fr)
*
|
1997-04-17 |
1998-10-22 |
Sekisui Chemical Co., Ltd. |
Particules conductrices, procede et dispositif de fabrication, structure anisotrope a adhesif et raccordement conducteur, composants de circuit electronique et leur procede de fabrication
|
|
AU5756298A
(en)
|
1997-04-18 |
1998-11-13 |
Gesellschaft Fur Biotechnologische Forschung Mbh |
Attenuated salmonella strain used as a vehicle for oral immunization
|
|
AU3710597A
(en)
|
1997-08-06 |
1999-03-01 |
Laboratorio Medinfar-Produtos Farmaceuticos, Lda |
Dna integration into "mycobacterium spp." genome by trans-complementation using a site-specific integration system
|
|
EP0902086A1
(en)
|
1997-08-22 |
1999-03-17 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Tuberculosis vaccine
|
|
US20040013685A1
(en)
|
1997-11-10 |
2004-01-22 |
Peter Andersen |
Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
|
|
US6099848A
(en)
|
1997-11-18 |
2000-08-08 |
The Trustees Of The University Of Pennsylvania |
Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
|
|
GB9726555D0
(en)
|
1997-12-16 |
1998-02-11 |
Smithkline Beecham Plc |
Vaccine
|
|
US6306404B1
(en)
|
1998-07-14 |
2001-10-23 |
American Cyanamid Company |
Adjuvant and vaccine compositions containing monophosphoryl lipid A
|
|
US6004815A
(en)
|
1998-08-13 |
1999-12-21 |
The Regents Of The University Of California |
Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells
|
|
EP1135415B1
(en)
|
1998-12-01 |
2010-08-11 |
Facet Biotech Corporation |
Humanized antibodies to gamma-interferon
|
|
US7198920B1
(en)
|
1999-01-29 |
2007-04-03 |
Corika Corporation |
HER-2/neu fusion proteins
|
|
EP1159429A2
(en)
|
1999-02-18 |
2001-12-05 |
Compugen Ltd. |
Psa and klk-2 splicing variants
|
|
JP2003516360A
(ja)
|
1999-12-09 |
2003-05-13 |
カイロン コーポレイション |
中枢神経系およびリンパ系に対するサイトカイン投与方法
|
|
US9012141B2
(en)
*
|
2000-03-27 |
2015-04-21 |
Advaxis, Inc. |
Compositions and methods comprising KLK3 of FOLH1 antigen
|
|
US6855320B2
(en)
|
2000-03-29 |
2005-02-15 |
The Trustees Of The University Of Pennsylvania |
Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity
|
|
EP1303299B1
(en)
|
2000-03-29 |
2010-07-28 |
The Trustees of The University of Pennsylvania |
Use of prokaryotic pest-like peptides for enhancing immunogenicity of antigens
|
|
CA2405247A1
(en)
|
2000-04-19 |
2001-10-25 |
Statens Serum Institut |
Tuberculosis antigens and methods of use thereof
|
|
US7199229B2
(en)
|
2000-08-11 |
2007-04-03 |
Mount Sinai Hospital |
Kallikrein gene
|
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
|
US7700344B2
(en)
|
2001-03-26 |
2010-04-20 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for enhancing the immunogenicity of antigens
|
|
WO2003008537A2
(en)
|
2001-04-06 |
2003-01-30 |
Mannkind Corporation |
Epitope sequences
|
|
US7432304B2
(en)
|
2001-05-30 |
2008-10-07 |
The Regents Of The University Of Michigan |
Small molecule antagonists of Bcl-2 family proteins
|
|
FR2825633B1
(fr)
|
2001-06-11 |
2005-12-16 |
Bio Veto Tests Bvt |
Complexe vaccinal therapeutique destine a la prevention et au traitement des leishmanioses et des infections a microorganismes pathogenes intracellulaires chez le mammifere
|
|
AU2003215084A1
(en)
|
2002-02-06 |
2003-09-02 |
The Johns Hopkins University |
Methods and compositions for the targeting of a systemic immune response to specific organs or tissues
|
|
US7425449B2
(en)
|
2002-04-30 |
2008-09-16 |
The Regents Of The University Of California |
Site specific Listeria integration vectors and methods for using the same
|
|
WO2003102168A1
(en)
|
2002-05-29 |
2003-12-11 |
The Regents Of The University Of California |
Attenuated listeria spp. and methods for using the same
|
|
PT1537878E
(pt)
|
2002-07-03 |
2010-11-18 |
Ono Pharmaceutical Co |
Composições de imunopotenciação
|
|
AU2003259109A1
(en)
|
2002-07-12 |
2004-02-02 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
EP1408048A1
(en)
|
2002-10-07 |
2004-04-14 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Vaccines of enhanced immunogenicity, and methods for preparing such vaccines
|
|
WO2004056875A1
(en)
|
2002-12-23 |
2004-07-08 |
Wyeth |
Antibodies against pd-1 and uses therefor
|
|
US8337861B2
(en)
*
|
2003-01-09 |
2012-12-25 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
|
|
WO2004072286A1
(ja)
|
2003-01-23 |
2004-08-26 |
Ono Pharmaceutical Co., Ltd. |
ヒトｐｄ−１に対し特異性を有する物質
|
|
DK1592441T3
(da)
|
2003-02-06 |
2012-05-14 |
Aduro Biotech |
Listeria, hvis indtrængen i ikke-phagocytiske celler er svækket, vacciner omfattende listeria og fremgangsmåder til anvendelse deraf
|
|
DE10310261A1
(de)
|
2003-03-05 |
2004-09-23 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Identifizierung von Antigen-Epitopen
|
|
US20050281783A1
(en)
|
2003-10-15 |
2005-12-22 |
Kinch Michael S |
Listeria-based EphA2 vaccines
|
|
US7556814B2
(en)
|
2003-10-23 |
2009-07-07 |
Karp Nelson M |
Immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) devoid of CD55 and CD59 in the viral membrane
|
|
WO2005061534A2
(en)
|
2003-12-23 |
2005-07-07 |
Statens Serum Institut |
Improved tuberculosis vaccines
|
|
WO2005071088A2
(en)
|
2003-12-24 |
2005-08-04 |
Cerus Corporation |
Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
|
|
US7842289B2
(en)
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
|
US7855064B2
(en)
*
|
2004-08-13 |
2010-12-21 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free vaccines and methods for constructing and using same
|
|
US7858097B2
(en)
|
2004-08-13 |
2010-12-28 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free Listeria strains and methods for constructing and using same
|
|
CA2577306A1
(en)
*
|
2004-08-13 |
2006-02-16 |
The Trustees Of The University Of Pennsylvania |
Methods for constructing antibiotic resistance free vaccines
|
|
AU2005295158A1
(en)
|
2004-10-18 |
2006-04-27 |
Medimmune, Llc |
High cell density process for growth of Listeria
|
|
PL2161336T5
(pl)
|
2005-05-09 |
2017-10-31 |
Ono Pharmaceutical Co |
Ludzkie przeciwciała monoklonalne przeciwko białku Programmed Death 1 (PD-1) oraz sposoby leczenia raka z zastosowaniem samych przeciwciał anty-PD-1 lub w połączeniu z innymi środkami immunoterapeutycznymi
|
|
CN100424096C
(zh)
|
2005-06-16 |
2008-10-08 |
华东理工大学 |
含有hiv转导结构域的生存素突变体及制备方法和应用
|
|
CA2612241C
(en)
|
2005-07-01 |
2018-11-06 |
Medarex, Inc. |
Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
|
|
WO2007061848A2
(en)
|
2005-11-17 |
2007-05-31 |
The Trustees Of The University Of Pennsylvania |
Methods for producing, growing, and preserving listeria vaccine vectors
|
|
RU2006112025A
(ru)
*
|
2005-12-16 |
2007-10-27 |
Хелт Рисерч Инк. (Us) |
Пептиды для стимуляции иммунного ответа против меланомы
|
|
US20070207171A1
(en)
*
|
2006-03-01 |
2007-09-06 |
Cerus Corporation |
Engineered listeria and methods of use thereof
|
|
EP2860253B1
(en)
*
|
2006-03-01 |
2018-08-01 |
Aduro Biotech, Inc. |
Engineered listeria and methods of use thereof
|
|
US7935804B2
(en)
*
|
2006-03-01 |
2011-05-03 |
Aduro Biotech |
Engineered Listeria and methods of use thereof
|
|
NZ596269A
(en)
|
2006-07-05 |
2012-12-21 |
Catalyst Biosciences Inc |
Protease screening methods and proteases identified thereby
|
|
WO2008008311A1
(en)
|
2006-07-10 |
2008-01-17 |
The Trustees Of The University Of Pennsylvania |
Methods for administering tumor vaccines
|
|
WO2008094188A2
(en)
|
2006-07-17 |
2008-08-07 |
Anza Therapeutics, Inc. |
Methods and compositions using listeria for enhancing immunogenicity by prime boost
|
|
EP2056849A4
(en)
|
2006-08-04 |
2010-09-08 |
Univ Pennsylvania |
METHOD AND COMPOSITIONS FOR TREATING IGE-MEDIATED ILLNESSES
|
|
US8268326B2
(en)
|
2006-08-15 |
2012-09-18 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
|
WO2008130551A2
(en)
*
|
2007-04-16 |
2008-10-30 |
The Trustees Of The University Of Pennsylvania |
Antibiotic resistance free listeria strains and methods for constructing and using same
|
|
KR101586617B1
(ko)
|
2007-06-18 |
2016-01-20 |
머크 샤프 앤 도메 비.브이. |
사람 프로그램된 사멸 수용체 ｐｄ-1에 대한 항체
|
|
WO2009110950A1
(en)
|
2007-12-31 |
2009-09-11 |
The Trustees Of The University Of Pennsylvania |
Attenuated listeria strain and adenovirus strain vaccines and methods of use
|
|
US8168757B2
(en)
|
2008-03-12 |
2012-05-01 |
Merck Sharp & Dohme Corp. |
PD-1 binding proteins
|
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
|
CN102076843A
(zh)
|
2008-05-19 |
2011-05-25 |
艾杜罗生物科技公司 |
包含prfa*突变体李斯特菌的组合物及其使用方法
|
|
US20120135033A1
(en)
|
2008-05-19 |
2012-05-31 |
Anu Wallecha |
Multiple delivery system for heterologous antigens
|
|
EP2853269B1
(en)
|
2008-05-19 |
2019-05-01 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens comprising a recombinant Listeria strain attenuated by mutation of dal/dat and deletion of ActA comprising a nucleic acid molecule encoding an listeriolysin O - prostate specific anigen fusion protein
|
|
JP2012500652A
(ja)
|
2008-08-25 |
2012-01-12 |
アンプリミューン、インコーポレーテッド |
標的化共刺激ポリペプチドおよび癌を処置するための使用方法
|
|
PL2342226T3
(pl)
|
2008-09-26 |
2017-01-31 |
Dana-Farber Cancer Institute, Inc. |
Ludzkie przeciwciała anty-PD-1, PD-L1 i PD-L2 oraz ich zastosowania
|
|
EP4209510B1
(en)
|
2008-12-09 |
2024-01-31 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
EP2498808A4
(en)
|
2009-11-11 |
2014-01-08 |
Advaxis |
COMPOSITIONS AND METHOD FOR PREVENTING FLUID MUTATIONS IN THE TREATMENT OF TUMORS WITH HER2 / NEW OVEREXPRESSION
|
|
US20130017199A1
(en)
|
2009-11-24 |
2013-01-17 |
AMPLIMMUNE ,Inc. a corporation |
Simultaneous inhibition of pd-l1/pd-l2
|
|
US20110223187A1
(en)
|
2010-02-15 |
2011-09-15 |
Vafa Shahabi |
Live listeria-based vaccines for central nervous system therapy
|
|
EP2739358B1
(en)
|
2011-08-01 |
2018-11-28 |
F.Hoffmann-La Roche Ag |
Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
|
|
AR093984A1
(es)
|
2012-12-21 |
2015-07-01 |
Merck Sharp & Dohme |
Anticuerpos que se unen a ligando 1 de muerte programada (pd-l1) humano
|
|
MX2015008329A
(es)
|
2012-12-27 |
2016-03-01 |
Aduro Biotech Inc |
Compañeros de fusion de peptido, señal que facilita la expresion listeral de secuencias antigenicas y metodos de preparacion y uso de los mismos.
|